Manufacturer of Controlled Substances; Notice of Application; Alltech Associates, Inc., 30331-30332 [2013-12114]

Download as PDF 30331 Federal Register / Vol. 78, No. 99 / Wednesday, May 22, 2013 / Notices in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745–46, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: May 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–12117 Filed 5–21–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Meridian Medical Technologies By Notice dated March 7, 2012, and published in the Federal Register on March 13, 2013, 78 FR 15974, Meridian Medical Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Morphine (9300), a basic class of controlled substance listed in schedule II. The company manufactures a product containing morphine in the United States. The company exports this product to customers around the world. The company has been asked to ensure that its product sold to European customers meets standards established by the European Pharmacopeia, which is administered by the Directorate of the Quality of Medicines (EDQM). In order to ensure that its product will meet European specifications, the company seeks to import morphine supplied by EDQM to use as reference standards. This is the sole purpose for which the company will be authorized by DEA to import morphine. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Meridian Medical Technologies to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Meridian Medical Technologies to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR § 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: May 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–12121 Filed 5–21–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Alltech Associates, Inc. Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 28, 2013, Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: TKELLEY on DSK3SPTVN1PROD with NOTICES Drug Schedule Methcathinone (1237) .................................................................................................................................................................................. N-Ethylamphetamine (1475) ........................................................................................................................................................................ N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. 4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... 2C-T-7 (2,5-Dimethoxy-4-(n)-Propylthiophenethylamine) (7348) ................................................................................................................ Tetrahydrocannabinols (7370) ..................................................................................................................................................................... Mescaline (7381) ......................................................................................................................................................................................... 2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine)(7385) ................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. 2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ 2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ 3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ 3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ 4-Methoxyamphetamine (7411) ................................................................................................................................................................... 5-Methoxy-N-N-dimethyltryptamine (7431) ................................................................................................................................................. Alpha-methyltryptamine (7432) ................................................................................................................................................................... Bufotenine (7433) ........................................................................................................................................................................................ Diethyltryptamine (7434) ............................................................................................................................................................................. Dimethyltryptamine (7435) .......................................................................................................................................................................... Psilocybin (7437) ......................................................................................................................................................................................... Psilocyn (7438) ............................................................................................................................................................................................ 5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... VerDate Mar<15>2010 16:59 May 21, 2013 Jkt 229001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 30332 Federal Register / Vol. 78, No. 99 / Wednesday, May 22, 2013 / Notices Drug Schedule 2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine) (7509) ....................................................................................................................... 2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) (7517) ................................................................................................................................... 2C-1(2-(4-lodo-2,5-dimethoxyphenyl)ethanamine) (7518) .......................................................................................................................... 2C-C (2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (7519) ...................................................................................................................... 2C-T-4 (2-(4-isopropylthio)-2,5-dimethoxyphenyl) ethanamine) (7532) ...................................................................................................... Dihydromorphine (9145) .............................................................................................................................................................................. Heroin (9200) ............................................................................................................................................................................................... Normorphine (9313) .................................................................................................................................................................................... Methamphetamine (1105) ........................................................................................................................................................................... 1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. Phencyclidine (7471) ................................................................................................................................................................................... Phenylacetone (8501) ................................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ Cocaine (9041) ............................................................................................................................................................................................ Codeine (9050) ............................................................................................................................................................................................ Dihydrocodeine (9120) ................................................................................................................................................................................ Ecgonine (9180) .......................................................................................................................................................................................... Meperidine intermediate-B (9233) ............................................................................................................................................................... Noroxymorphone (9668) .............................................................................................................................................................................. The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR § 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 22, 2013. Dated: May 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. The company plans to manufacture bulk active pharmaceutical ingredients (APIs) for distribution to its customers. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol as a synthetic intermediate. No other activity for this drug code is authorized for this registration. Any other such applicant, and any person who is presently registered with DEA to manufacture such substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR § 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 22, 2013. Dated: May 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–12114 Filed 5–21–13; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2013–12115 Filed 5–21–13; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration TKELLEY on DSK3SPTVN1PROD with NOTICES Manufacturer of Controlled Substances, Notice of Application, Austin Pharma, Llc. DEPARTMENT OF JUSTICE Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 28, 2013, Austin Pharma, LLC., 811 Paloma Drive, Suite C, Round Rock, Texas 78665– 2402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Marihuana (7360), a basic class of controlled substance listed in schedule I. Manufacturer of Controlled Substances, Notice of Application, Lin Zhi International, Inc. VerDate Mar<15>2010 16:59 May 21, 2013 Jkt 229001 Drug Enforcement Administration Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 3, 2013, Lin Zhi International, Inc., 670 Almanor Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk PO 00000 Frm 00066 Fmt 4703 Sfmt 9990 I I I I I I I I II II II II II II II II II II II manufacturer of the following basic classes of controlled substances: Drug Tetrahydrocannabinols (7370) 3,4-Methylenedioxymeth- amphetamine (7405). Cocaine (9041) ............................. Oxycodone (9143) ........................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Schedule I II II II II II II The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR § 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 22, 2013. Dated: May 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–12110 Filed 5–21–13; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\22MYN1.SGM 22MYN1

Agencies

[Federal Register Volume 78, Number 99 (Wednesday, May 22, 2013)]
[Notices]
[Pages 30331-30332]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12114]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Alltech Associates, Inc.

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 28, 2013, Alltech 
Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237)........................  I
N-Ethylamphetamine (1475)...................  I
N,N-Dimethylamphetamine (1480)..............  I
4-Methylaminorex (cis isomer) (1590)........  I
Alpha-ethyltryptamine (7249)................  I
Lysergic acid diethylamide (7315)...........  I
2C-T-7 (2,5-Dimethoxy-4-(n)-                  I
 Propylthiophenethylamine) (7348).
Tetrahydrocannabinols (7370)................  I
Mescaline (7381)............................  I
2C-T-2 (2-(4-Ethylthio-2,5-                   I
 dimethoxyphenyl)ethanamine)(7385).
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
2,5-Dimethoxy-4-ethylamphetamine (7399).....  I
3,4-Methylenedioxyamphetamine (7400)........  I
N-Hydroxy-3,4-methylenedioxyamphetamine       I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)....  I
4-Methoxyamphetamine (7411).................  I
5-Methoxy-N-N-dimethyltryptamine (7431).....  I
Alpha-methyltryptamine (7432)...............  I
Bufotenine (7433)...........................  I
Diethyltryptamine (7434)....................  I
Dimethyltryptamine (7435)...................  I
Psilocybin (7437)...........................  I
Psilocyn (7438).............................  I
5-Methoxy-N,N-diisopropyltryptamine (7439)..  I
N-Ethyl-1-phenylcyclohexylamine (7455)......  I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)....  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)  I

[[Page 30332]]

 
2C-E (2-(2,5-Dimethoxy-4-                     I
 ethylphenyl)ethanamine) (7509).
2C-H (2-(2,5-Dimethoxyphenyl)ethanamine)      I
 (7517).
2C-1(2-(4-lodo-2,5-                           I
 dimethoxyphenyl)ethanamine) (7518).
2C-C (2-(4-Chloro-2,5-                        I
 dimethoxyphenyl)ethanamine (7519).
2C-T-4 (2-(4-isopropylthio)-2,5-              I
 dimethoxyphenyl) ethanamine) (7532).
Dihydromorphine (9145)......................  I
Heroin (9200)...............................  I
Normorphine (9313)..........................  I
Methamphetamine (1105)......................  II
1-Phenylcyclohexylamine (7460)..............  II
Phencyclidine (7471)........................  II
Phenylacetone (8501)........................  II
1-Piperidinocyclohexanecarbonitrile (8603)..  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Dihydrocodeine (9120).......................  II
Ecgonine (9180).............................  II
Meperidine intermediate-B (9233)............  II
Noroxymorphone (9668).......................  II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical applications only in clinical, toxicological, and 
forensic laboratories.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR Sec.  1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than July 22, 2013.

    Dated: May 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-12114 Filed 5-21-13; 8:45 am]
BILLING CODE 4410-09-P